# How Does Dietary Carbohydrate Influence the Formation of an Atherogenic Lipoprotein Phenotype (ALP)?

> **NCT01790984** · NA · COMPLETED · sponsor: **Bruce A. Griffin** · enrollment: 27 (actual)

## Conditions studied

- Non-alcoholic Fatty Liver Disease (NAFLD)

## Interventions

- **OTHER:** High sugar low starch diet
- **OTHER:** Low sugar high starch diet

## Key facts

- **NCT ID:** NCT01790984
- **Lead sponsor:** Bruce A. Griffin
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2011-08
- **Final completion:** 2012-09
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2021-05-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01790984

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01790984, "How Does Dietary Carbohydrate Influence the Formation of an Atherogenic Lipoprotein Phenotype (ALP)?". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01790984. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*